News
President Donald Trump says pharma tariffs could go as high as 250%. UBS downgrades Novo Nordisk stock to neutral and lowers ...
MarketBeat on MSN56m
Novo Nordisk Stock Sinks—But Is a Bottom Finally In?Novo Nordisk (NYSE: NVO) stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is up more than 200%. However, in the last year, it’s down over 61% and more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback